Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.

about

Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.

P2860

Q42117021-935B42E3-6649-4957-921B-E8A8E571CC01 Q50350314-4431771B-0DE6-40CB-929D-C517D155F964

P2860

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.

Item

http://www.wikidata.org/entity/Q37381602

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Substantial expression of lute ...... ype I in human uveal melanoma.

@en

Substantial expression of luteinizing hormone-releasing hormone

@nl

type

Item

label

Substantial expression of lute ...... ype I in human uveal melanoma.

@en

Substantial expression of luteinizing hormone-releasing hormone

@nl

prefLabel

Substantial expression of lute ...... ype I in human uveal melanoma.

@en

Substantial expression of luteinizing hormone-releasing hormone

@nl

P1476

Substantial expression of lute ...... ype I in human uveal melanoma.

@en

P2093

Andras Berta

http://www.w3.org/2001/XMLSchema#string

Andrea Treszl

http://www.w3.org/2001/XMLSchema#string

Armin Buglyo

http://www.w3.org/2001/XMLSchema#string

Balazs Dezso

http://www.w3.org/2001/XMLSchema#string

Bernadett Rozsa

http://www.w3.org/2001/XMLSchema#string

Gabor Olah

http://www.w3.org/2001/XMLSchema#string

Janos Gardi

http://www.w3.org/2001/XMLSchema#string

Klara Fodor

http://www.w3.org/2001/XMLSchema#string

Norman L Block

http://www.w3.org/2001/XMLSchema#string

Zita Steiber

http://www.w3.org/2001/XMLSchema#string

P2860

Dormancy of metastatic melanoma

Does ocular treatment of uveal melanoma influence survival?

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

A prognostic model and staging for metastatic uveal melanoma.

Survival rates with uveal melanoma in the United States: 1973-1997.

Molecular prognostic testing and individualized patient care in uveal melanoma.

Chemotherapy targeted to cancers through tumoral hormone receptors.

Metastatic uveal melanoma therapy: current options.

Effectiveness of treatments for metastatic uveal melanoma.

Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (Review).

P304

1721-1728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1379

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Schally

Gabor Halmos

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257206039

http://www.w3.org/2001/XMLSchema#string

P698

24077773

http://www.w3.org/2001/XMLSchema#string

P932

3858558

http://www.w3.org/2001/XMLSchema#string

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.

about

P2860

P2860

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932